Inventor · disambiguated record
John Mancuso
Also filed as: MANCUSO JOHN
8 granted patents·11 pending applications·25 citations·filing 2005–2025
83Inventor score
Top patents by PatentIndex Score
19 records- 0194US11608344B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 21, 2023·4 cites·30 claims
- 0293US11912711B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Feb 27, 2024·3 cites·30 claims
- 0393US11884675B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Jan 30, 2024·3 cites·30 claims
- 0482US12428425B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Sep 30, 2025·0 cites·18 claims
- 0582US8673911B2Inhibitors of histone deacetylaseMALLAIS TAMMY·Filed 2008·Granted Mar 18, 2014·13 cites·2 claims
- 0667US2025042897A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 0766US8399452B2Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitorsDEZIEL ROBERT·Filed 2007·Granted Mar 19, 2013·1 cites·52 claims
- 0865US7321046B2Analogs of dictyostatin, intermediates therefor and methods of synthesis thereofUNIV PITTSBURGH·Filed 2005·Granted Jan 22, 2008·1 cites·6 claims
- 0959US9193749B2Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitorsFORUM PHARMACEUTICALS INC·Filed 2013·Granted Nov 24, 2015·0 cites·2 claims
- 1059US2025304580A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 1156US2024309003A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 1250US2016222026A1Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC InhibitorsFORUM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1348US2008188651A1Analogs of dictyostatin, intermediates therefor and methods of systhesis thereofCURRAN DENNIS P·Filed 2008·Application pending·0 cites
- 1447US2023234967A1Fused Azole Heterocycles as AHR AntagonistsSENDA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1547US2014045850A1Inhibitors of histone deacetylaseMETHYLGENE INC·Filed 2013·Application pending·0 cites
- 1646US2011196147A1Inhibitors of histone deacetylaseDEZIEL ROBERT·Filed 2011·Application pending·0 cites
- 1744US2023295152A1Pyridopyrimidinone derivatives as ahr antagonistsSENDA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1838US2006264415A1Inhibitors of histone deacetylaseMETHYLGENE INC·Filed 2006·Application pending·0 cites
- 1930US2017320908A1Solid phase synthesis of cyclic amino acid moleculesENCYCLE THERAPEUTICS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Mancuso files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →